Watson, J&J Settle Over Birth Control Generic

By Django Gold (February 8, 2012, 2:17 PM EST) -- Watson Laboratories on Wednesday announced that it has entered into an agreement with a Johnson & Johnson subsidiary by which the company will issue to Watson a generic version of J&J's Ortho Tri-Cyclen Lo birth control drug, days after the parties settled a related patent infringement suit in New Jersey....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!